The digital health fund, launched by Astellas Pharma and MPM Capital late last month, will initially look to invest up to $6m in two to three deals per year.
DigiTx Partners, the digital healthcare venture capital fund recently formed by pharmaceutical company Astellas Pharma and MPM Capital, will invest up to $6m in each deal but plans to start small, according to chief executive David Kim.
DigiTx was launched by the firms in late July, and will target early-stage digital health companies, with a particular focus on technologies where care can be improved in conjunction with pharmaceuticals. Kim identified patient compliance technology, data-assisted disease risk analysis and clinical…
